BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Healthtrust
Express Scripts
Queensland Health
Baxter
Citi
Accenture
Harvard Business School
Mallinckrodt
Dow

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016042

« Back to Dashboard

NDA 016042 describes DYAZIDE, which is a drug marketed by Glaxosmithkline Llc and is included in one NDA. It is available from two suppliers. Additional details are available on the DYAZIDE profile page.

The generic ingredient in DYAZIDE is hydrochlorothiazide; triamterene. There are thirty-one drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 016042
Tradename:DYAZIDE
Applicant:Glaxosmithkline Llc
Ingredient:hydrochlorothiazide; triamterene
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 016042
Suppliers and Packaging for NDA: 016042
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DYAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 016042 NDA GlaxoSmithKline LLC 0007-3650 0007-3650-22 100 CAPSULE in 1 BOTTLE (0007-3650-22)
DYAZIDE hydrochlorothiazide; triamterene CAPSULE;ORAL 016042 NDA GlaxoSmithKline LLC 0007-3650 0007-3650-30 1000 CAPSULE in 1 BOTTLE (0007-3650-30)

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength25MG;50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength25MG;37.5MG
Approval Date:Mar 3, 1994TE:ABRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Express Scripts
Cerilliant
Chinese Patent Office
Federal Trade Commission
Fuji
Chubb
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot